An experimental study of individuals with moderate to severe alcohol use disorder found that semaglutide did not reduce a ...

Study: Once-Weekly Semaglutide in Adults With Alcohol Use Disorder A Randomized Clinical Trial. Image Credit: simon jhuan/Shutterstock.com A recent JAMA Psychiatry study investigates the effectiveness ...

A clinical trial led by researchers at CU Anschutz has found that oral semaglutide, a medication widely used for diabetes and weight loss, reduces heavy drinking in adults with alcohol use disorder ...

The first published evidence from humans that semaglutide specifically reduces the symptoms of alcohol use disorder (AUD) has been published in The Journal of Clinical Psychiatry and details a recent ...

A new study by researchers at the Case Western Reserve University School of Medicine reveals that the popular diabetes and weight-loss drugs Wegovy and Ozempic are linked to reduced incidence and ...

People with alcohol use disorder who took semaglutide, also known as Wegovy, drank less and had fewer cravings for alcohol, new research found. Reading time 3 minutes A study out this week suggests ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

A long-term study suggests GLP-1 agonists, especially semaglutide, may lower the risk of alcohol use disorder hospitalizations, highlighting the potential for novel treatments pending further clinical ...

Share on Pinterest Semaglutide drugs were tied to a significantly lower incidence of alcohol use disorder in a new study. Image credit: JNemchinova/Getty Images. A new study from Case Western Reserve ...

A clinical trial led by researchers at CU Anschutz has found that oral semaglutide, a medication widely used for diabetes and weight loss, reduces heavy drinking in adults with Alcohol Use Disorder ...

A new study showed that semaglutide may help with alcohol use disorder Steve Christo - Corbis/Corbis via Getty; Getty A new study (the first clinical trial of its kind) has shown that the GLP-1 ...

AURORA, Colo., July 29, 2026 /PRNewswire/ -- A clinical trial led by researchers at CU Anschutz has found that oral semaglutide, a medication widely used for diabetes and weight loss, reduces heavy ...